Skip To Main Content
Licinio Craveiro on Muck Rack

Licinio Craveiro

As seen in: JAMA Network, Neurology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Licinio

Contact Licinio, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis : The OPERA I and II Randomized Clinical Trials

|
By Stephen L. Hauser, Amit Bar-Or, Gavin Giovannoni, Xavier Montalban, Christine Lebrun-Frenay, Lilyana Amezcua, Luisa M. Villar, Douglas Arnold, Martin Weber, Massimo Filippi, Noemi Pasquarelli, Cathy Chognot, Qing Wang, Hans-Martin Schneble, Licinio Craveiro, Ludwig Kappos
| JAMA Network Verified
Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials Supplement 1. Trial Protocols and Statistical Analysis Plan Supplement 2. eMethods. Supplemental Methods eFigure 1. Time to Study Withdrawal eFigure 2. Patient Disposition eTable 1. Patient Demographics and Disease Characteristics at Baseline and Last Known Follow-Up: Treatment-Naive and Recently Diagnosed, Treatment-Naive Patients Who Completed Open-Label Extension eFigure 3.
Open in Who Shared Issue with article?

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

|
By Stephen L. Hauser, Ludwig Kappos, Xavier Montalban, Licinio Craveiro
| Neurology Verified
Abstract Background and Objectives To report safety of ocrelizumab (OCR) up to 7 years in patients with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) enrolled in clinical trials or treated in real-world postmarketing settings.
Open in Who Shared Issue with article?
See all 2 articles